5 Best Cancer Stocks To Buy Now

Page 1 of 5

In this article, we discuss the 5 best cancer stocks to buy now. If you want to read our detailed analysis of these companies, go directly to read the 10 Best Cancer Stocks To Buy Now.

5. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 67

Pfizer Inc. (NYSE:PFE) is a New York-based pharmaceutical giant. In 2020, the company’s breast cancer drug, Ibrance, generated $5.39 billion in sales. In the second quarter of 2021, the drugmaker’s revenue in the cancer segment grew 19% year over year to $3.15 billion. And with over 32 cancer drug pipelines, Pfizer Inc. (NYSE:PFE) is one of the 10 best cancer stocks to buy now.

On October 12, Matthew Harrison of Morgan Stanley increased his price target for Pfizer Inc. (NYSE:PFE) to $48 from $45, while maintaining an Equal-Weight rating. In September, the drug manufacturer declared a quarterly dividend of $0.39 per share. Pfizer Inc. (NYSE:PFE) offers a forward dividend yield of 3.55%.

Of the 873 elite funds tracked by Insider Monkey, 67 hedge funds were long Pfizer Inc. (NYSE:PFE) in Q2 2021, compared with 65 in the previous quarter. 

Pfizer Inc. (NYSE:PFE) shares are up 17.2% year to date after the FDA recommended approval of the drugmaker’s COVID-19 vaccine for children. The FDA approved Pfizer Inc.’s (NYSE:PFE) COVID-19 booster shot in September.

Page 1 of 5